UPDATED Apr 09, 2024
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SXE | AU$1.10 | 3.3% | 73.2% | AU$289.4m | n/a | PE14.5x | n/a | 4.5% | Capital Goods | ||
PPS | AU$0.43 | 6.1% | -41.2% | AU$211.2m | n/a | PE21x | E17.4% | n/a | Software | ||
BTI | AU$1.28 | 0% | 7.1% | AU$186.9m | n/a | PE5.7x | n/a | 5.3% | Diversified Financials | ||
CAA | AU$9.36 | 0% | 25.5% | AU$165.0m | n/a | PE5.2x | E-6.5% | 5.9% | Materials | ||
BRL | AU$0.85 | -1.7% | -22.0% | AU$162.7m | n/a | PE3.3x | n/a | 0% | Materials | ||
VLS | AU$2.28 | -6.6% | 60.6% | AU$129.8m | n/a | PE14.3x | n/a | 3.9% | Pharmaceuticals & Biotech | ||
TPC | AU$11.32 | 3.2% | 335.4% | AU$128.4m | n/a | PE14.5x | n/a | 5.3% | Utilities | ||
HNG | AU$0.40 | -4.8% | 37.9% | AU$119.9m | n/a | PE14.7x | n/a | 3.8% | Capital Goods | ||
KOV | AU$9.00 | 1.1% | 20.0% | AU$105.1m | n/a | PE8.5x | n/a | 6.7% | Capital Goods | ||
BBL | AU$1.01 | -2.9% | -5.6% | AU$99.0m | n/a | PE17.6x | n/a | 1.5% | Media | ||
ECL | AU$3.29 | 3.1% | 28.0% | AU$95.4m | n/a | PE9.3x | n/a | 2.1% | Capital Goods | ||
MEA | AU$0.59 | 0.8% | 65.3% | AU$94.7m | n/a | PE8x | n/a | 5.0% | Real Estate Management and Development | ||
LBL | AU$0.74 | 0% | -15.9% | AU$86.4m | AU$1.25 | PE19.4x | E33.3% | 2.2% | Capital Goods | ||
HIT | AU$2.02 | 3.1% | 6.3% | AU$85.4m | n/a | PE14.6x | n/a | 5.0% | Commercial Services | ||
MAM | AU$0.60 | 1.7% | -1.6% | AU$78.5m | n/a | PE13.7x | n/a | 5.5% | Diversified Financials | ||
APW | AU$1.59 | 7.5% | 21.9% | AU$70.6m | n/a | PB0.5x | n/a | 0% | Real Estate | ||
SKS | AU$0.47 | 5.6% | 163.9% | AU$52.2m | n/a | PE26.8x | n/a | 0.4% | Capital Goods | ||
NGE | AU$1.02 | 1.0% | 37.8% | AU$36.5m | n/a | PE4.1x | n/a | n/a | Diversified Financials | ||
EZZ | AU$0.76 | 16.9% | 78.8% | AU$32.5m | AU$1.46 | PE9.3x | S11.9% | 1.3% | Pharmaceuticals & Biotech | ||
CTE | AU$0.64 | -8.6% | -12.3% | AU$31.2m | n/a | PE19.8x | n/a | 2.3% | Pharmaceuticals & Biotech | ||
EGF | AU$0.24 | 0% | n/a | AU$238.8k | n/a | PB0.2x | n/a | 14.6% | Banks |